Search research articles
Contact Us
Filters
Showing results (201-210 of 251) with videos related to
Page
of 26
Sort By:
Genes and Immunity
|
September 3, 2004
HLA-DRB1, TAP2/TAP1, and HLA-DPB1 haplotypes in Finnish juvenile idiopathic arthritis: more complexity within the MHC
J A Runstadler, H Säilä, A Savolainen, et al.
Genomics
|
September 1, 1987
Prenatal diagnosis of X-linked chronic granulomatous disease using restriction fragment length polymorphism analysis
M Lindlöf, J Kere, M Ristola, et al.
Genes and Immunity
|
July 9, 2003
Analysis of MHC region genetics in Finnish patients with juvenile idiopathic arthritis: evidence for different locus-specific effects in polyarticular vs pauciarticular subsets and a shared DRB1 epitope
J A Runstadler, H Säilä, A Savolainen, et al.
Diabetes Care
|
July 1, 1993
Seven years of remission in a type I diabetic patient
V A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
Clinical and Experimental Rheumatology
|
May 21, 2010
Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis
E Martín-Mola, J Sieper, M Leirisalo-Repo, et al.
Scandinavian Journal of Rheumatology
|
April 17, 2008
Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression
M Hakala, J Risteli, S Aman, et al.
Scandinavian Journal of Rheumatology
|
March 11, 2009
Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis
K Puolakka, H Kautiainen, T Mottonen, et al.
Scandinavian Journal of Rheumatology
|
June 23, 2025
Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study
T Sandström, O Kaipiainen-Seppänen, M Mali, et al.
Clinical and Experimental Rheumatology
|
May 18, 2005
Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug
A Kuuliala, M Leirisalo-Repo, T Möttönen, et al.
Rheumatology (Oxford, England)
|
December 22, 2004
How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience
K Kaarela, M Hakala, P Hannonen, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 251) with videos related to
Sort By:
Page
of 26
Genes and Immunity
|
September 3, 2004
HLA-DRB1, TAP2/TAP1, and HLA-DPB1 haplotypes in Finnish juvenile idiopathic arthritis: more complexity within the MHC
J A Runstadler, H Säilä, A Savolainen, et al.
Genomics
|
September 1, 1987
Prenatal diagnosis of X-linked chronic granulomatous disease using restriction fragment length polymorphism analysis
M Lindlöf, J Kere, M Ristola, et al.
Genes and Immunity
|
July 9, 2003
Analysis of MHC region genetics in Finnish patients with juvenile idiopathic arthritis: evidence for different locus-specific effects in polyarticular vs pauciarticular subsets and a shared DRB1 epitope
J A Runstadler, H Säilä, A Savolainen, et al.
Diabetes Care
|
July 1, 1993
Seven years of remission in a type I diabetic patient
V A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
Clinical and Experimental Rheumatology
|
May 21, 2010
Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis
E Martín-Mola, J Sieper, M Leirisalo-Repo, et al.
Scandinavian Journal of Rheumatology
|
April 17, 2008
Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression
M Hakala, J Risteli, S Aman, et al.
Scandinavian Journal of Rheumatology
|
March 11, 2009
Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis
K Puolakka, H Kautiainen, T Mottonen, et al.
Scandinavian Journal of Rheumatology
|
June 23, 2025
Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study
T Sandström, O Kaipiainen-Seppänen, M Mali, et al.
Clinical and Experimental Rheumatology
|
May 18, 2005
Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug
A Kuuliala, M Leirisalo-Repo, T Möttönen, et al.
Rheumatology (Oxford, England)
|
December 22, 2004
How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience
K Kaarela, M Hakala, P Hannonen, et al.
Page
of 26